Tiotropium Bromide in Cystic Fibrosis
NCT01179347
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
464
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
tiotropium Respimat® inhaler
DRUG:
Placebo Respimat® inhaler
Sponsor
Boehringer Ingelheim